ADMA vs MTTR
ADMA Biologics Inc (ADMA) versus MTTR (MTTR) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
MTTR (MTTR) common stock.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
MTTR does not have a complete income-statement cache yet.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Not investment advice. Open the ADMA and MTTR stock pages for the full models.
Not investment advice.